100 related articles for article (PubMed ID: 16879394)
21. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
Simiantonaki N; Jayasinghe C; Michel-Schmidt R; Peters K; Hermanns MI; Kirkpatrick CJ
Int J Oncol; 2008 Mar; 32(3):585-92. PubMed ID: 18292935
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
[TBL] [Abstract][Full Text] [Related]
23. Endostatin variations in childhood acute lymphoblastic leukaemia--comparison with basic fibroblast growth factor and vascular endothelial growth factor.
Schneider P; Vasse M; Corbière C; Legrand E; Marie-Cardine A; Boquet C; Cazin L; Vannier JP
Leuk Res; 2007 May; 31(5):629-38. PubMed ID: 17011029
[TBL] [Abstract][Full Text] [Related]
24. Immunolocalization of VEGF, VEGFR-1 and VEGFR-2 in lung tissues after acute hemorrhage in rats.
Ekerbicer N; Tarakci F; Barut T; Inan S
Acta Histochem; 2008; 110(4):285-93. PubMed ID: 18321563
[TBL] [Abstract][Full Text] [Related]
25. Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence.
Wu S; Gessner R; von Stackelberg A; Kirchner R; Henze G; Seeger K
Cancer; 2005 Mar; 103(5):1054-63. PubMed ID: 15651075
[TBL] [Abstract][Full Text] [Related]
26. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K
Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004
[TBL] [Abstract][Full Text] [Related]
27. Malignant hematopoietic cells induce an increased expression of VEGFR-1 and VEGFR-3 on bone marrow endothelial cells via AKT and mTOR signalling pathways.
Mirshahi P; Toprak SK; Faussat AM; Dubrulle S; Marie JP; Soria C; Soria J; Mirshahi M
Biochem Biophys Res Commun; 2006 Oct; 349(3):1003-10. PubMed ID: 16959214
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical analysis of VEGF-C/VEGFR-3 system and lymphatic vessel extent in normal and adenomatous human pituitary tissues.
Onofri C; Losa M; Uhl E; Stalla GK; Renner U
Exp Clin Endocrinol Diabetes; 2008 Mar; 116(3):152-7. PubMed ID: 18205092
[TBL] [Abstract][Full Text] [Related]
29. The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma.
Mylona E; Alexandrou P; Giannopoulou I; Liapis G; Sofia M; Keramopoulos A; Nakopoulou L
Gynecol Oncol; 2007 Mar; 104(3):557-63. PubMed ID: 17150246
[TBL] [Abstract][Full Text] [Related]
30. Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomas.
Itakura E; Yamamoto H; Oda Y; Tsuneyoshi M
J Surg Oncol; 2008 Jan; 97(1):74-81. PubMed ID: 18041747
[TBL] [Abstract][Full Text] [Related]
31. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
32. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
33. Expression and localization of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in human epidermal appendages: a comparison study by immunofluorescence.
Man XY; Yang XH; Cai SQ; Bu ZY; Wu XJ; Lu ZF; Zheng M
Clin Exp Dermatol; 2009 Apr; 34(3):396-401. PubMed ID: 19309374
[TBL] [Abstract][Full Text] [Related]
34. Endogenous vascular endothelial growth factor-C expression is associated with decreased drug responsiveness in childhood acute myeloid leukemia.
de Jonge HJ; Weidenaar AC; Ter Elst A; Boezen HM; Scherpen FJ; Bouma-Ter Steege JC; Kaspers GJ; Goemans BF; Creutzig U; Zimmermann M; Kamps WA; de Bont ES
Clin Cancer Res; 2008 Feb; 14(3):924-30. PubMed ID: 18245556
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
[TBL] [Abstract][Full Text] [Related]
36. Expression of the vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukemia: incidence and feasibility of immunohistochemical staining.
Kharfan-Dabaja MA; Patel SA; Osunkoya AO; Kojouri K; Kamble R; Yang J; Hashmi M; Ozer H; Selby GB
Clin Lab Haematol; 2006 Aug; 28(4):254-8. PubMed ID: 16898965
[TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.
Issa A; Le TX; Shoushtari AN; Shields JD; Swartz MA
Cancer Res; 2009 Jan; 69(1):349-57. PubMed ID: 19118020
[TBL] [Abstract][Full Text] [Related]
38. Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy.
Zhou Z; Bolontrade MF; Reddy K; Duan X; Guan H; Yu L; Hicklin DJ; Kleinerman ES
Clin Cancer Res; 2007 Aug; 13(16):4867-73. PubMed ID: 17699866
[TBL] [Abstract][Full Text] [Related]
39. [Expression and clinical significance of vascular endothelial growth factor C and D in nasopharyngeal carcinoma].
Zhao GG; Xiang XJ; He YJ
Ai Zheng; 2007 Jan; 26(1):90-5. PubMed ID: 17222375
[TBL] [Abstract][Full Text] [Related]
40. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF.
Dardik R; Inbal A
Exp Cell Res; 2006 Oct; 312(16):2973-82. PubMed ID: 16914140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]